Silexion Therapeutics SLXN Q2 2025 earnings
Reported August 12, 2025 · Before market open
EPS-$4.32Miss by $1.17
EPS estimate-$3.15
Next report
Aug 11, 2026 (In 1 week)EPS estimate-$21.20
Versus estimates
Diluted EPS
Ask the moment Silexion Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Silexion Therapeutics report Q2 2025 earnings?
- Silexion Therapeutics (SLXN) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Silexion Therapeutics's Q2 2025 revenue and EPS?
- Silexion Therapeutics reported eps of $-4.32 for Q2 2025.
- Did Silexion Therapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-3.15 by $1.17.
- How did Silexion Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 336.4% from $-0.99.
- Where can I find Silexion Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001178913-25-002804) directly on SEC EDGAR. The filing index links above go to sec.gov.